You are here

Novo Nordisk

Novo Nordisk's blockbuster Ozempic wins FDA label boost with CV indication

Endpoints

Fri, 01/17/20 - 11:15 am

cardiovascular events

FDA OKs Novo's Fiasp for diabetic children

Seeking Alpha

Mon, 01/6/20 - 10:36 am

type 1 diabetes

Novo Nordisk Launches $99 Insulin Program

BioSpace

Thu, 01/2/20 - 11:41 pm

Novo Nordisk joins with UVA in diabetes digital simulation project

Pharmaforum

Fri, 12/20/19 - 12:08 pm

type 2 diabetes

ICER Warns of ‘Short-Term Budget Challenges’ with Novo’s Rybelsus

Xtalks

Tue, 12/10/19 - 10:35 am

oral semaglutide

Novo Nordisk CEO Jørgensen aims to leverage diabetes know-how, deals into the new decade

Fierce Pharma

Wed, 11/20/19 - 10:45 pm

Lars Fruergaard Jorgensen

AZ, Merck and Novartis top Big Pharma's Q3 growth charts. Teva and Pfizer? Not so much

Fierce Pharma

Tue, 11/19/19 - 11:38 pm

Novo Ventures Sows $25M Into Accelerator to Break Into Illustrious Mass Bio Space

Xconomy

Tue, 11/19/19 - 10:45 am

Broad Institute

Dicerna scores broad, 'rest of liver' deal with Novo Nordisk, bagging $225M in cash to hit some 30 targets with RNAi platform

Endpoints

Mon, 11/18/19 - 11:33 pm

Novo Nordisk buys rights to NASH drug from Japan’s UBE

Pharmaforum

Fri, 11/8/19 - 10:49 am

Novo Nordisk (NVO) Q3 Earnings Beat Estimates, Revenues Miss

Yahoo/Zacks.com

Mon, 11/4/19 - 10:15 am

Novo drops oral GLP-1 analog to focus on next-gen Rybelsus

Fierce Biotech

Fri, 11/1/19 - 10:36 am

oral semaglutide

Why Novo Nordisk should buy Uniqure

EP Vantage

Fri, 10/11/19 - 10:31 am

Novo taps bluebird bio for gene-editing tech

Fierce Biotech

Wed, 10/9/19 - 09:43 am

Novo Nordisk announces obesity digital health tie-up with Noom

Pharmaforum

Thu, 10/3/19 - 10:53 am

Mom approved: J&J, Takeda and more lead Working Mother's best places to work list for 2019

Fierce Pharma

Wed, 10/2/19 - 10:53 am

How Big Can This $8 Billion-Plus Diabetes Drug Class Get?

Motley Fool

Fri, 09/27/19 - 09:10 am

Novo’s new oral GLP-1 Rybelsus still has obstacles to overcome

Pharmaforum

Tue, 09/24/19 - 09:53 am

oral semaglutide

Novo Nordisk wins FDA green light for 'holy grail' diabetes drug Rybelsus

Fierce Pharma

Fri, 09/20/19 - 01:13 pm

oral semaglutide

type 2 diabetes

Novo and Sanofi make case for hypo-reducing insulins at EASD

Pharmaforum

Thu, 09/19/19 - 09:59 am

Pages